Tianjin Tianyao Pharmaceuticals Hits Day High with 9.9% Surge

Tianjin Tianyao Pharmaceuticals Co., Ltd. has experienced a significant uptick in its stock performance, gaining 9.9% on March 27, 2026. The stock reached an intraday high of CNY 4.33, marking a notable achievement for the small-cap company in the Pharmaceuticals & Biotechnology sector. In terms of performance metrics, Tianjin Tianyao has shown resilience over the past week, with an 8.25% increase compared to a decline of 1.09% in the China Shanghai Composite. Over the past month, the stock has risen by 1.64%, while the broader market has faced a downturn of 5.99%. Year-to-date, the company has outperformed the index, with a gain of 5.87% against a loss of 1.39% for the composite. Despite these recent gains, the company faces challenges, including a low Return on Capital Employed (ROCE) of 4.51% and a declining trend in net sales and operating profit over the past five years. The stock's performance over the longer term has been less favorable, with a three-year decline of 2.26% and a five-year drop of 14.26%. As it stands, Tianjin Tianyao Pharmaceuticals continues to navigate a complex financial landscape.